Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems

Non-viral vectors for gene-based therapy

Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123

Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA

Karikó, K., Buckstein, M., Ni, H., & Weissman, D. (2005) · Immunity · doi:10.1016/j.immuni.2005.06.008 · Cited by 2,728

Gold nanoparticles in delivery applications☆

GHOSH, P., HAN, G., De, M., KIM, C., & Rotello, V. M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.016 · Cited by 2,700

Progress and problems with the use of viral vectors for gene therapy

Thomas, C. E., Ehrhardt, A., & Kay, M. A. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1066 · Cited by 2,501

mRNA-based therapeutics--developing a new class of drugs

Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474

New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?

Feng, S.-S. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.297 · Cited by 1,951

Rational design of cationic lipids for siRNA delivery

Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822

Delivery materials for siRNA therapeutics

Kanasty, R., Dorkin, J. R., Vegas, A., & Anderson, D. (2013) · Nature Materials · doi:10.1038/nmat3765 · Cited by 1,800

Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape

Gilleron, J., Querbes, W., Zeigerer, A., Borodovsky, A., Marsico, G., Schubert, U., Manygoats, K., Seifert, S., Andree, C., Stöter, M., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2612 · Cited by 1,681

An Inverted Hexagonal Phase of Cationic Liposome-DNA Complexes Related to DNA Release and Delivery

Koltover, I., Salditt, T., Rädler, J. O., & Safinya, C. R. (1998) · Science · doi:10.1126/science.281.5373.78 · Cited by 1,336

Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo

Jayaraman, M., Ansell, S. M., Mui, B. L., Tam, Y. K., Chen, J., Du, X., Butler, D., Eltepu, L., Matsuda, S., Narayanannair, J. K., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203263 · Cited by 1,267

Self-Assembled Lipid−Polymer Hybrid Nanoparticles: A Robust Drug Delivery Platform

Zhang, L., Chan, J. M., Gu, F., Rhee, J., Wang, A. Z., Radovic‐Moreno, A. F., Alexis, F., Langer, R., & Farokhzad, O. C. (2008) · ACS Nano · doi:10.1021/nn800275r · Cited by 1,042

Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes

Pardi, N., Tuyishime, S., Muramatsu, H., Kariko, K., Mui, B. L., Tam, Y. K., Madden, T. D., Hope, M. J., & Weissman, D. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.007 · Cited by 1,014

Chitosan-based formulations for delivery of DNA and siRNA

Mao, S., Sun, W., & Kissel, T. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.08.004 · Cited by 970

Cationic liposome-mediated RNA transfection.

Malone, R. W., Felgner, P. L., & Verma, I. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6077 · Cited by 911

Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo

Yin, H., Song, C.-Q., Dorkin, J. R., Zhu, L. J., Li, Y., Wu, Q., Park, A., Yang, J., Suresh, S., Bizhanova, A., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3471 · Cited by 876

Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs

Kauffman, K. J., Dorkin, J. R., Yang, J. H., Heartlein, M. W., DeRosa, F., Mir, F. F., Fenton, O. S., & Anderson, D. G. (2015) · Nano Letters · doi:10.1021/acs.nanolett.5b02497 · Cited by 796

Expression of therapeutic proteins after delivery of chemically modified mRNA in mice

Kormann, M. S. D., Hasenpusch, G., Aneja, M. K., Nica, G., Flemmer, A. W., Herber-Jonat, S., Huppmann, M., Mays, L. E., Illenyi, M., Schams, A., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1733 · Cited by 733

Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown

Wittrup, A., Ai, A., Liu, X., Hamar, P., Trifonova, R., Charisse, K., Manoharan, M., Kirchhausen, T., & Lieberman, J. (2015) · Nature Biotechnology · doi:10.1038/nbt.3298 · Cited by 693

Nonviral delivery of self-amplifying RNA vaccines

Geall, A. J., Verma, A., Otten, G. R., Shaw, C. A., Hekele, A., Banerjee, K., Cu, Y., Beard, C. W., Brito, L. A., Krucker, T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209367109 · Cited by 675

Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction

Zangi, L., Lui, K. O., von Gise, A., Ma, Q., Ebina, W., Ptaszek, L. M., Später, D., Xu, H., Tabebordbar, M., Gorbatov, R., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2682 · Cited by 646

Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells

Holtkamp, S., Kreiter, S., Selmi, A., Simon, P., Koslowski, M., Huber, C., Türeci, O., & Sahin, U. (2006) · Blood · doi:10.1182/blood-2006-04-015024 · Cited by 625

Cationic lipids, lipoplexes and intracellular delivery of genes

Wasungu, L., & Hoekstra, D. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.06.024 · Cited by 616

Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity

Whitehead, K. A., Dorkin, J. R., Vegas, A. J., Chang, P. H., Veiseh, O., Matthews, J., Fenton, O. S., Zhang, Y., Olejnik, K. T., Yesilyurt, V., et al. (2014) · Nature Communications · doi:10.1038/ncomms5277 · Cited by 615

Nucleic Acid Therapeutics Using Polyplexes: A Journey of 50 Years (and Beyond)

Lächelt, U., & Wagner, E. (2015) · Chemical Reviews · doi:10.1021/cr5006793 · Cited by 607

Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids

Heyes, J., Palmer, L., Bremner, K., & MacLachlan, I. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.06.014 · Cited by 572

Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus

Brunner, S., Sauer, T., Carotta, S., Cotten, M. L., Saltik, M., & Wagner, E. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301102 · Cited by 534

Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals

Thess, A., Grund, S., Mui, B. L., Hope, M. J., Baumhof, P., Fotin-Mleczek, M., & Schlake, T. (2015) · Molecular Therapy · doi:10.1038/mt.2015.103 · Cited by 513

Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates

Dong, Y., Love, K. T., Dorkin, J. R., Sirirungruang, S., Zhang, Y., Chen, D., Bogorad, R. L., Yin, H., Chen, Y., Vegas, A. J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322937111 · Cited by 488

Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial

Alton, E. W. F. W., Armstrong, D. K., Ashby, D., Bayfield, K. J., Bilton, D., Bloomfield, E. V., Boyd, A. C., Brand, J., Buchan, R., Calcedo, R., et al. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00245-3 · Cited by 428

Materials for non-viral intracellular delivery of messenger RNA therapeutics

Kauffman, K. J., Webber, M. J., & Anderson, D. G. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.032 · Cited by 407

Folate-targeted, Anionic Liposome-entrapped Polylysine-condensed DNA for Tumor Cell-specific Gene Transfer

Lee, R. J., & Huang, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.14.8481 · Cited by 400

Characterization of cationic lipid-protamine–DNA (LPD) complexes for intravenous gene delivery

Li, S., Rizzo, M., Bhattacharya, S. S., & Huang, L. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300683 · Cited by 369

Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L

Anderson, B. R., Muramatsu, H., Jha, B. K., Silverman, R. H., Weissman, D., & Kariko, K. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr586 · Cited by 356

A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines

Brito, L. A., Chan, M., Shaw, C. A., Hekele, A., Carsillo, T., Schaefer, M., Archer, J., Seubert, A., Otten, G. R., Beard, C. W., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.133 · Cited by 338

In Vitro and in Vivo mRNA Delivery Using Lipid-Enveloped pH-Responsive Polymer Nanoparticles

Su, X., Fricke, J., Kavanagh, D. G., & Irvine, D. J. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100390w · Cited by 287

Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin

Karikó, K., Muramatsu, H., Keller, J. M., & Weissman, D. (2012) · Molecular Therapy · doi:10.1038/mt.2012.7 · Cited by 282

Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides

Nafee, N. A., Taetz, S., Schneider, M., Schaefer, U. F., & Lehr, C. (2007) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2007.03.006 · Cited by 264

Results of the First Phase I/II Clinical Vaccination Trial With Direct Injection of mRNA

Weide, B., Carralot, J.-P., Reese, A., Scheel, B., Eigentler, T. K., Hoerr, I., Rammensee, H.-G., Garbe, C., & Pascolo, S. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31815ce501 · Cited by 261

Bioinspired Alkenyl Amino Alcohol Ionizable Lipid Materials for Highly Potent In Vivo mRNA Delivery

Fenton, O. S., Kauffman, K. J., McClellan, R. L., Appel, E. A., Dorkin, J. R., Tibbitt, M. W., Heartlein, M. W., DeRosa, F., Langer, R., & Anderson, D. G. (2016) · Advanced Materials · doi:10.1002/adma.201505822 · Cited by 252

Immunocompatibility properties of lipid–polymer hybrid nanoparticles with heterogeneous surface functional groups

Salvador-Morales, C., Zhang, L., Langer, R., & Farokhzad, O. C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.005 · Cited by 251

The regulation of mRNA stability in mammalian cells: 2.0

Wu, X., & Brewer, G. (2012) · Gene · doi:10.1016/j.gene.2012.03.021 · Cited by 239

mRNA as gene therapeutic: How to control protein expression

Tavernier, G., Andries, O., Demeester, J., Sanders, N. N., De Smedt, S. C., & Rejman, J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.020 · Cited by 232

Non-Viral Gene Delivery Methods

Wang, W., Li, W., Ma, N., & Steinhoff, G. (2013) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201011314010008 · Cited by 229

Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA

Perche, F., Benvegnu, T. J., Berchel, M., Lebegue, L., Pichon, C., Jaffrès, P., & Midoux, P. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2010.12.010 · Cited by 228

Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated Patients

Rittig, S. M., Haentschel, M., Weimer, K. J., Heine, A., Muller, M. R., Brugger, W., Horger, M. S., Maksimovic, O., Stenzl, A., Hoerr, I., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2010.289 · Cited by 226

Rapidly produced SAM ® vaccine against H7N9 influenza is immunogenic in mice

Hekele, A., Bertholet, S., Archer, J., Gibson, D. G., Palladino, G., Brito, L. A., Otten, G. R., Brazzoli, M., Buccato, S., Bonci, A., et al. (2013) · Emerging Microbes & Infections · doi:10.1038/emi.2013.54 · Cited by 226

Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cells

Bettinger, T. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.18.3882 · Cited by 224

Odd–Even Effect of Repeating Aminoethylene Units in the Side Chain of N-Substituted Polyaspartamides on Gene Transfection Profiles

Uchida, H., Miyata, K., Oba, M., Ishii, T., Suma, T., Itaka, K., Nishiyama, N., & Kataoka, K. (2011) · Journal of the American Chemical Society · doi:10.1021/ja204466y · Cited by 216

Noncytopathic Sindbis virus RNA vectors for heterologous gene expression

Agapov, E. V., Frolov, I. V., Lindenbach, B. D., Prágai, B. M., Schlesinger, S., & Rice, C. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.12989 · Cited by 214

Lipid-based mRNA vaccine delivery systems

Midoux, P., & Pichon, C. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2015.986104 · Cited by 213

Biodegradable polyamino acid-based polycations as safe and effective gene carrier minimizing cumulative toxicity

Itaka, K., Ishii, T., Hasegawa, Y., & Kataoka, K. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.11.072 · Cited by 211

A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients

Wilgenhof, S., Nuffel, A. M. T. V., Benteyn, D., Corthals, J., Aerts, C., Heirman, C., Riet, I. V., Bonehill, A., Thielemans, K., & Neyns, B. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt245 · Cited by 204

Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra- and paracellular pathways

Li, M., Zhao, M., Fu, Y., Li, Y., Gong, T., Zhang, Z., & Sun, X. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.02.043 · Cited by 201

Current prospects for mRNA gene delivery

Yamamoto, A., Kormann, M., Rosenecker, J., & Rudolph, C. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.016 · Cited by 200

Mammalian germ-line transgenesis by transposition

Dupuy, A. J., Clark, K. J., Carlson, C. M., Fritz, S., Davidson, A. E., Markley, K. M., Finley, K., Fletcher, C., Ekker, S. C., Hackett, P. B., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062630599 · Cited by 196

Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy.

Wang, Y.-H., Su, H.-H., Yang, Y., Hu, Y.-X., Zhang, L., Blancafort, P., & Huang, L. (2013) · Molecular Therapy · doi:10.1038/mt.2012.250 · Cited by 189

A Clinical Inflammatory Syndrome Attributable to Aerosolized Lipid–DNA Administration in Cystic Fibrosis

Ruiz, F. E., Clancy, J. P., Perricone, M. A., Bebok, Z. M., Hong, J. S., Cheng, S. H., Meeker, D. P., Young, K. R., Schoumacher, R., Weatherly, M. R., et al. (2001) · Human Gene Therapy · doi:10.1089/104303401750148667 · Cited by 184

mRNA-based cancer vaccine: prevention of B16 melanoma progression and metastasis by systemic injection of MART1 mRNA histidylated lipopolyplexes

Mockey, M., Bourseau, E., Voshavar, C., Chaudhuri, A., Lafosse, S., Cam, É. L., Quesniaux, V. F. J., Ryffel, B., Pichon, C., & Midoux, P. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701072 · Cited by 167

Breaking the Bonds: Non-viral Vectors Become Chemically Dynamic

Wolff, J. A., & Rozema, D. B. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300326 · Cited by 165

Gene transfer to the lung: Lessons learned from more than 2 decades of CF gene therapy

Uta Griesenbach, D., & Alton, E. W. F. W. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.010 · Cited by 164

Lipid-mediated delivery of RNA is more efficient than delivery of DNA in non-dividing cells

Zou, S., Scarfo, K. A., Nantz, M. H., & Hecker, J. G. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.01.019 · Cited by 161

Transposon-mediated BAC transgenesis in zebrafish and mice

Suster, M. L., Sumiyama, K., & Kawakami, K. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-477 · Cited by 161

Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system

DeRosa, F., Guild, B., Karve, S., Smith, L., Love, K., Dorkin, J. R., Kauffman, K. J., Zhang, J., Yahalom, B., Anderson, D. G., et al. (2016) · Gene Therapy · doi:10.1038/gt.2016.46 · Cited by 159

Polymer vectors via controlled/living radical polymerization for gene delivery

Xu, F., & Yang, W. (2011) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2010.11.005 · Cited by 157

Systemic delivery of messenger RNA for the treatment of pancreatic cancer using polyplex nanomicelles with a cholesterol moiety

Uchida, S., Kinoh, H., Ishii, T., Matsui, A., Tockary, T. A., Takeda, K. M., Uchida, H., Osada, K., Itaka, K., & Kataoka, K. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.12.031 · Cited by 151

Latest Developments in Gene Transfer Technology: Achievements, Perspectives, and Controversies over Therapeutic Applications

Romano, G., Micheli, P., Pacilio, C., & Giordano, A. (2000) · Stem Cells · doi:10.1634/stemcells.18-1-19 · Cited by 150

Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**

Jayaraman, M., Ansell, S. M., Mui, B. L., Tam, Y. K., Chen, J., Du, X., Butler, D., Eltepu, L., Matsuda, S., Narayanannair, J. K., et al. (2012) · Angewandte Chemie · doi:10.1002/ange.201203263 · Cited by 150

Modulated Protonation of Side Chain Aminoethylene Repeats in N-Substituted Polyaspartamides Promotes mRNA Transfection

Uchida, H., Itaka, K., Nomoto, T., Ishii, T., Suma, T., Ikegami, M., Miyata, K., Oba, M., Nishiyama, N., & Kataoka, K. (2014) · Journal of the American Chemical Society · doi:10.1021/ja506194z · Cited by 147

In vivo genome editing using nuclease-encoding mRNA corrects SP-B deficiency

Mahiny, A. J., Dewerth, A., Mays, L. E., Alkhaled, M., Mothes, B., Malaeksefat, E., Loretz, B., Rottenberger, J., Brosch, D. M., Reautschnig, P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3241 · Cited by 139

In Vivo Messenger RNA Introduction into the Central Nervous System Using Polyplex Nanomicelle

Uchida, S., Itaka, K., Uchida, H., Hayakawa, K., Ogata, T., Ishii, T., Fukushima, S., Osada, K., & Kataoka, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056220 · Cited by 133

mRNA transfection of cervical carcinoma and mesenchymal stem cells mediated by cationic carriers

Rejman, J., Tavernier, G., Bavarsad, N., Demeester, J., & Smedt, S. C. D. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.07.124 · Cited by 133

Multifunctional triblock copolymers for intracellular messenger RNA delivery

Cheng, C., Convertine, A. J., Stayton, P. S., & Bryers, J. D. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.06.020 · Cited by 123

A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs

Kallen, K., & Theß, A. (2013) · Therapeutic Advances in Vaccines · doi:10.1177/2051013613508729 · Cited by 122

Viral and Non-viral Vectors in Gene Therapy: Technology Development and Clinical Trials

Lundstrom, K. H., & Boulikas, T. (2003) · Technology in Cancer Research & Treatment · doi:10.1177/153303460300200513 · Cited by 120

Tumor vaccination using messenger RNA: prospects of a future therapy

Kreiter, S., Diken, M., Selmi, A., Türeci, Ö., & Şahin, U. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.03.007 · Cited by 120

Efficient genetic modification of murine dendritic cells by electroporation with mRNA

Meirvenne, S. V., Straetman, L., Heirman, C., Dullaers, M., Greef, C. D., Tendeloo, V. F. V., & Thielemans, K. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700499 · Cited by 118

The potential of antigen and TriMix sonoporation using mRNA-loaded microbubbles for ultrasound-triggered cancer immunotherapy

Dewitte, H., Lint, S. V., Heirman, C., Thielemans, K., Smedt, S. C. D., Breckpot, K., & Lentacker, I. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.08.011 · Cited by 118

mRNA-Lipoplex loaded microbubble contrast agents for ultrasound-assisted transfection of dendritic cells

Temmerman, M. D., Dewitte, H., Vandenbroucke, R. E., Lucas, B., Libert, C., Demeester, J., Smedt, S. C. D., Lentacker, I., & Rejman, J. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.024 · Cited by 116

RNA as a Source of Transposase for Sleeping Beauty-Mediated Gene Insertion and Expression in Somatic Cells and Tissues

Wilber, A. C., Frandsen, J. L., Geurts, J. L., Largaespada, D. A., Hackett, P. B., & McIvor, R. S. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.10.014 · Cited by 115

Chemically modified RNA activated matrices enhance bone regeneration

Elangovan, S., Khorsand, B., Do, A., Hong, L., Dewerth, A., Kormann, M., Ross, R. D., Sumner, D. R., Allamargot, C., & Salem, A. K. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.050 · Cited by 114

Nonviral transfection of distinct types of human dendritic cells: high-efficiency gene transfer by electroporation into hematopoietic progenitor- but not monocyte-derived dendritic cells

Tendeloo, V. F. V., Snoeck, H.-W., Lardon, F., Vanham, G. L., Nijs, G., Lenjou, M., Hendriks, L., Broeckhoven, C. V., Moulijn, A. C., Rodrigus, I. R., et al. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300626 · Cited by 112

Myocardial Delivery of Lipidoid Nanoparticle Carrying modRNA Induces Rapid and Transient Expression

Turnbull, I. C., Eltoukhy, A. A., Fish, K. M., Nonnenmacher, M. E., Ishikawa, K., Chen, J., Hajjar, R. J., Anderson, D. G., & Costa, K. D. (2015) · Molecular Therapy · doi:10.1038/mt.2015.193 · Cited by 112

Poly(glycoamidoamine) Brushes Formulated Nanomaterials for Systemic siRNA and mRNA Delivery in Vivo

Dong, Y., Dorkin, J. R., Wang, W., Chang, P., Webber, M. J., Tang, B. C., Yang, J., Ionita, I. A., Danino, D., DeRosa, F., et al. (2016) · Nano Letters · doi:10.1021/acs.nanolett.5b02428 · Cited by 111

Treatment of neurological disorders by introducing mRNA in vivo using polyplex nanomicelles

Baba, M., Itaka, K., Kondo, K., Yamasoba, T., & Kataoka, K. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.017 · Cited by 109

Effect of PEGylation on Biodistribution and Gene Silencing of siRNA/Lipid Nanoparticle Complexes

Bao, Y., Jin, Y., Chivukula, P., Zhang, J., Liu, Y., Liu, J., Clamme, J., Mahato, R. I., Ng, D., Ying, W., et al. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0874-6 · Cited by 107

Chemically modified RNA induces osteogenesis of stem cells and human tissue explants as well as accelerates bone healing in rats

Balmayor, E. R., Geiger, J. P., Aneja, M. K., Berezhanskyy, T., Utzinger, M., Mykhaylyk, O., Rudolph, C., & Plank, C. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.02.018 · Cited by 105

Development of Novel Biodegradable Polymeric Nanoparticles-in-Microsphere Formulation for Local Plasmid DNA Delivery in the Gastrointestinal Tract

Bhavsar, M. D., & Amiji, M. M. (2008) · AAPS PharmSciTech · doi:10.1208/s12249-007-9021-9 · Cited by 104

A single methylene group in oligoalkylamine‐based cationic polymers and lipids promotes enhanced mRNA delivery

Jarzębińska, A., Pasewald, T., Lambrecht, J., Mykhaylyk, O., Kümmerling, L., Beck, P., Hasenpusch, G., Rudolph, C., Plank, C., & Dohmen, C. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201603648 · Cited by 101

Synthesis and Characterization of Lipid–Polymer Hybrid Nanoparticles with pH-Triggered Poly(ethylene glycol) Shedding

Clawson, C., Ton, L., Aryal, S., Fu, V., Esener, S. C., & Zhang, L. (2011) · Langmuir · doi:10.1021/la202123e · Cited by 93

Design of Ionizable Lipids To Overcome the Limiting Step of Endosomal Escape: Application in the Intracellular Delivery of mRNA, DNA, and siRNA

Habrant, D., Peuziat, P., Colombani, T., Dallet, L., Gehin, J., Emilie, G., Berangere, E., Lambert, O., Haudebourg, T., & Pitard, B. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01679 · Cited by 91

Optimization of methods to achieve mRNA-mediated transfection of tumor cells in vitro and in vivo employing cationic liposome vectors.

Lu, D., Benjamin, R., Kim, M., Conry, R. M., & Curiel, D. (1994) · PubMed · Cited by 89

Gene Transfer Technology in Therapy: Current Applications and Future Goals

Romano, G., Pacilio, C., & Giordano, A. (1999) · Stem Cells · doi:10.1002/stem.170191 · Cited by 89

Overexpression of urokinase receptor in mammalian cells following administration of the in vitro transcribed encoding mRNA

Karikó, K., Kuo, A., & Barnathan, E. S. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300930 · Cited by 89

A simple and highly efficient transgenesis method in mice with the Tol2 transposon system and cytoplasmic microinjection

Sumiyama, K., Kawakami, K., & Yagita, K. (2010) · Genomics · doi:10.1016/j.ygeno.2010.02.006 · Cited by 85

Sendai virus vectors as an emerging negative‐strand RNA viral vector system

Bitzer, M., Armeanu, S., Lauer, U. M., & Neubert, W. J. (2003) · The Journal of Gene Medicine · doi:10.1002/jgm.426 · Cited by 85

Transfection of cells using flow-through electroporation based on constant voltage

Geng, T., Zhan, Y., Wang, J., & Lu, C. (2011) · Nature Protocols · doi:10.1038/nprot.2011.360 · Cited by 80

Effective delivery with enhanced translational activity synergistically accelerates mRNA-based transfection

Zohra, F. T., Chowdhury, E. H., Tada, S., Hoshiba, T., & Akaike, T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.059 · Cited by 71

Lipid‐Like Nanomaterials for Simultaneous Gene Expression and Silencing In Vivo

Dong, Y., Eltoukhy, A. A., Alabi, C. A., Khan, O. F., Omid Veiseh, A., Dorkin, J. R., Sirirungruang, S., Yin, H., Tang, B. C., Pelet, J. M., et al. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201400054 · Cited by 60

High performance mRNA transfection through carbonate apatite–cationic liposome conjugates

Zohra, F. T., Chowdhury, E. H., & Akaike, T. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.050 · Cited by 58

A functionalized gold nanoparticles-assisted universal carrier for antisense DNA

Kim, J., Jang, H. H., Ryou, S.-M., Kim, S., Bae, J., Lee, K., & Han, M. S. (2010) · Chemical Communications · doi:10.1039/c0cc00103a · Cited by 57

Innate immune response and programmed cell death following carrier-mediated delivery of unmodified mRNA to respiratory cells

Andries, O., Filette, M. D., Smedt, S. C. D., Demeester, J., Poucke, M. V., Peelman, L. J., & Sanders, N. N. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.01.033 · Cited by 54

Peptide-enhanced mRNA transfection in cultured mouse cardiac fibroblasts and direct reprogramming towards cardiomyocyte-like cells

Murthy, N., Lee, K., Yu, P., Lingampalli, N., Kim, H. J., & Tang, R. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s75124 · Cited by 53

A defective nontransmissible recombinant Sendai virus mediates efficient gene transfer to airway epithelium in vivo

Ferrari, S., Uta Griesenbach, D., Shiraki-Iida, T., Shu, T., Hironaka, T., Hou, X., Williams, J. L., Zhu, J., Jeffery, P. K., Geddes, D. M., et al. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302334 · Cited by 53

PEGylation Improves Nanoparticle Formation and Transfection Efficiency of Messenger RNA

Üzgün, S., Nica, G., Pfeifer, C., Bosinco, M., Michaelis, K., Lutz, J., Schneider, M., Rosenecker, J., & Rudolph, C. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0464-z · Cited by 51

Inhibition of Xenograft Tumor Growth by Gold Nanoparticle-DNA Oligonucleotide Conjugates-Assisted Delivery of BAX mRNA

Yeom, J., Ryou, S.-M., Won, M., Park, M., Bae, J., & Lee, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075369 · Cited by 51

Nebulisation of IVT mRNA Complexes for Intrapulmonary Administration

Johler, S. M., Rejman, J., Guan, S., & Rosenecker, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137504 · Cited by 46

mRNA delivery using non-viral PCL nanoparticles

Palamà, I. E., Cortese, B., D’Amone, S., & Gigli, G. (2014) · Biomaterials Science · doi:10.1039/c4bm00242c · Cited by 44

Effects of local structural transformation of lipid-like compounds on delivery of messenger RNA

Li, B., Luo, X. L., Deng, B., Giancola, J. B., McComb, D. W., Schmittgen, T. D., & Dong, Y. (2016) · Scientific Reports · doi:10.1038/srep22137 · Cited by 44

Mannosylated and Histidylated LPR Technology for Vaccination with Tumor Antigen mRNA

Pichon, C., & Midoux, P. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-260-5_16 · Cited by 42

Exogenous mRNA delivery and bioavailability in gene transfer mediated by piggyBac transposition

Bire, S., Gosset, D., Jégot, G., Midoux, P., Pichon, C., & Rouleux‐Bonnin, F. (2013) · BMC Biotechnology · doi:10.1186/1472-6750-13-75 · Cited by 41

Viral and Non-Viral Approaches for Transient Delivery of mRNA and Proteins

Schott, J. W., Galla, M., Godinho, T., Baum, C., & Schambach, A. (2011) · Current Gene Therapy · doi:10.2174/156652311797415872 · Cited by 40

Nuclear targeting of viral and non-viral DNA

Chowdhury, E. H. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903025744 · Cited by 36

Interaction of Poliovirus-Specific RNAs with HeLa Cells and E. coli

Koch, G. (1973) · Modern aspects of electrochemistry · doi:10.1007/978-3-642-65772-6_4 · Cited by 32

Insertional Mutagenesis by a Hybrid PiggyBac and Sleeping Beauty Transposon in the Rat

Furushima, K., Jang, C., Chen, D. W., Xiao, N., Overbeek, P. A., & Behringer, R. R. (2012) · Genetics · doi:10.1534/genetics.112.140855 · Cited by 28

Transferrin-Lipoplexes with Protamine-Condensed DNA for Serum-Resistant Gene Delivery

de Ilarduya, C. T., Arangoa, M. A., & Düzgüneş, N. (2003) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(03)73022-5 · Cited by 26

Drastic effect of nanoapatite particles on liposome-mediated mRNA delivery to mammalian cells

Zohra, F. T., Chowdhury, E. H., Nagaoka, M., & Akaike, T. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.06.031 · Cited by 26

mRNA Delivery through Fibronectin Associated Liposome-Apatite Particles: A New Approach for Enhanced mRNA Transfection to Mammalian Cell

Zohra, F. T., Maitani, Y., & Akaike, T. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.35.111 · Cited by 21

In vivo imaging of gene transfer to the respiratory tract

Uta Griesenbach, D., Meng, C., Farley, R., Cheng, S. H., Scheule, R. K., Davies, M. H., Wolstenholme-Hogg, P. C., ten Hove, W., van der Hoeven, P., Sinn, P. L., et al. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.11.017 · Cited by 14

Cytoplasmic expression systems triggered by mRNA yield increased gene expression in post-mitotic neurons

Farrow, P. J. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl442 · Cited by 11

A Broad Range of Dose Optima Achieve High-level, Long-term Gene Expression After Hydrodynamic Delivery of Sleeping Beauty Transposons Using Hyperactive SB100x Transposase

Podetz-Pedersen, K. M., Olson, E. R., Somia, N. V., Russell, S. J., & McIvor, R. S. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.54 · Cited by 6

Untitled work

Hoerr, I. (2000) · doi:10.1002/1521-4141(200001)30:1

mRNA vaccines — a new era in vaccinology

Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667

Lipid nanoparticles for mRNA delivery

Hou, X., Zaks, T., Langer, R., & Dong, Y. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00358-0 · Cited by 4,076

Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery

Kowalski, P. S., Rudra, A., Miao, L., & Anderson, D. G. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.02.012 · Cited by 1,127

The clinical progress of mRNA vaccines and immunotherapies

Barbier, A. J., Jiang, A. Y., Zhang, P., Wooster, R., & Anderson, D. G. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01294-2 · Cited by 823

Advances in mRNA Vaccines for Infectious Diseases

Zhang, C., Maruggi, G., Shan, H., & Li, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00594 · Cited by 696

Evading innate immunity in nonviral mRNA delivery: don't shoot the messenger.

Devoldere, J., Dewitte, H., De Smedt, S. C., & Remaut, K. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.07.009 · Cited by 112

Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives

Gómez-Aguado, I., Rodríguez-Castejón, J., Vicente-Pascual, M., Rodríguez‐Gascón, A., Solinís, M. Á., & del Pozo‐Rodríguez, A. (2020) · Nanomaterials · doi:10.3390/nano10020364 · Cited by 229

Potential and pitfalls of non-viral mRNA delivery for ocular therapies

Devoldere, J. (2019) · Ghent University Academic Bibliography (Ghent University)

mRNA-based therapies: Preclinical and clinical applications

Qureischi, M., Mohr, J., Arellano-Viera, E., Knudsen, S. E., Vohidov, F., & Garitano-Trojaola, A. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.04.007 · Cited by 21

Nonviral Delivery Systems of mRNA Vaccines for Cancer Gene Therapy

Wang, Y., Zhang, R., Tang, L., & Li, Y. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030512 · Cited by 58